SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001140361-21-016016
Filing Date
2021-05-05
Accepted
2021-05-05 19:02:07
Documents
2
Period of Report
2021-05-01

Document Format Files

Seq Description Document Type Size
1 FORM 3 form3.html 3  
1 FORM 3 form3.xml 3 1459
2 EXHIBIT 24 brhc10024061_ex24.htm EX-24 9042
  Complete submission text file 0001140361-21-016016.txt   12155
Mailing Address 140 58TH STREET, BUILDING A SUITE 2100 BROOKLYN NY 11220
Business Address 140 58TH STREET, BUILDING A SUITE 2100 BROOKLYN NY 11220 (212) 582-1199
Brooklyn ImmunoTherapeutics, Inc. (Issuer) CIK: 0000748592 (see all company filings)

IRS No.: 311103425 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences

Mailing Address 320 WAKARA WAY SALT LAKE CITY UT 84108
Business Address
LANGER DENNIS (Reporting) CIK: 0001274225 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-11460 | Film No.: 21895126